Evidence map›Paper›PMID 41899491›Full record

ArticleCurrent issues in molecular biology2026

Correction: Zsengellér et al. Mitigating Oxidative Stress and Anti-Angiogenic State in an In Vitro Model of Preeclampsia by HY-12, an Organofluorine Hydrazone Antioxidant.

Zsuzsanna K Zsengellér, Maxim Mastyugin, Adrianna R Fusco, Bernadett Vlocskó, Maximilian Costa, Coryn Ferguson, Diana Pintye, Réka Eszter Sziva, Saira Salahuddin, Brett C Young and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Zsuzsanna K ZsengellérDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.ORCID 0000-0002-4540-5728
Maxim MastyuginDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Adrianna R FuscoDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Bernadett VlocskóDepartment of Chemistry, University of Massachusetts Boston, Boston, MA 02125, USA.ORCID 0009-0004-6373-2257
Maximilian CostaDepartment of Chemistry, University of Massachusetts Boston, Boston, MA 02125, USA.
Coryn FergusonDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Diana PintyeDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Réka Eszter SzivaDepartment of OB/GYN, Semmelweis University, 1082 Budapest, Hungary.
Saira SalahuddinDepartment of OB/GYN, Beth Israel Lahey Health, Boston, MA 02215, USA.
Brett C YoungDepartment of OB/GYN, Mt Auburn Hospital, Boston, MA 02138, USA.ORCID 0000-0002-7715-1283
Marianna TörökDepartment of Chemistry, University of Massachusetts Boston, Boston, MA 02125, USA.ORCID 0000-0002-2343-1984
Béla TörökDepartment of Chemistry, University of Massachusetts Boston, Boston, MA 02125, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID41899491
PMCPMC13024958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.